{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T14:19:28Z","timestamp":1756995568699},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1986,1,1]],"date-time":"1986-01-01T00:00:00Z","timestamp":504921600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacologia"],"published-print":{"date-parts":[[1986,1]]},"DOI":"10.1007\/bf00310514","type":"journal-article","created":{"date-parts":[[2004,10,10]],"date-time":"2004-10-10T13:01:10Z","timestamp":1097413270000},"page":"63-65","source":"Crossref","is-referenced-by-count":42,"title":["Homovanillic acid in caudate and pre-frontal cortex following acute and chronic neuroleptic administration"],"prefix":"10.1007","volume":"88","author":[{"suffix":"Jr.","given":"Malcolm B.","family":"Bowers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Frederick J.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF00310514_CR1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF00569723","volume":"312","author":"T Alander","year":"1980","unstructured":"Alander T, Anden N-E, Grabowska-Anden M (1980) Metoclopramide and sulpiride as selective blocking agents of pre- and post-synaptic dopamine receptors. Arch Pharmacol 312:145\u2013150","journal-title":"Arch Pharmacol"},{"key":"BF00310514_CR2","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0014-2999(73)90028-9","volume":"22","author":"H Asper","year":"1973","unstructured":"Asper H, Baggiolini M, Burki HR, Lauener H, Ruch W, Stille G (1973) Tolerance phenomena with neuroleptics \u2014 catalepsy, apomorphine stereotypies and striatal dopamine metabolism in the rat after single and repeated administration of loxapine and haloperidol. Eur J Pharmacol 22:287\u2013294","journal-title":"Eur J Pharmacol"},{"key":"BF00310514_CR3","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1126\/science.38504","volume":"205","author":"NG Bacopoulos","year":"1979","unstructured":"Bacopoulos NG, Spokes EG, Bird ED, Roth RH (1979) Antipsychotic drug action in schizophrenic patients: effect on cortical dopamine metabolism after long-term treatment. Science 205:1405\u20131407","journal-title":"Science"},{"key":"BF00310514_CR4","first-page":"22","volume":"221","author":"NG Bacopoulos","year":"1982","unstructured":"Bacopoulos NG, Bustos G, Redmond DE Jr, Roth RH (1982) Chronic treatment with haloperidol or fluphenazine decanoate: regional effects on dopamine and serotonin metabolism in primate brain. J Pharmacol Exp Ther 221:22\u201328","journal-title":"J Pharmacol Exp Ther"},{"key":"BF00310514_CR5","first-page":"270","volume":"19","author":"MJ Bannon","year":"1981","unstructured":"Bannon MJ, Michaud RL, Roth RH (1981) Mesocortical dopamine neurons: lack of autoreceptors modulating dopamine synthesis. Mol Pharmacol 19:270\u2013275","journal-title":"Mol Pharmacol"},{"key":"BF00310514_CR6","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/296444a0","volume":"296","author":"MJ Bannon","year":"1982","unstructured":"Bannon MJ, Reinhardt JF Jr, Bunney EB, Roth RH (1982) Unique response to antipsychotic drugs is due to absence of terminal autoreceptors in mesocortical dopamine neurons. Nature 296:444\u2013446","journal-title":"Nature"},{"key":"BF00310514_CR7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0014-2999(83)90116-4","volume":"91","author":"MJ Bannon","year":"1983","unstructured":"Bannon MJ, Wolf ME, Roth RH (1983) Pharmacology of dopamine neurons innervating the prefrontal, cingulate, and piriform cortices. Eur J Pharmacol 91:119\u2013125","journal-title":"Eur J Pharmacol"},{"key":"BF00310514_CR8","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.2042-7158.1974.tb09365.x","volume":"26","author":"MB Bowers Jr","year":"1974","unstructured":"Bowers MB Jr, Rozitis A (1974) Regional differences in homovanillic acid concentrations after acute and chronic administration of antipsychotic drugs. J Pharm Pharmacol 26:743\u2013745","journal-title":"J Pharm Pharmacol"},{"key":"BF00310514_CR9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0014-2999(84)90438-2","volume":"99","author":"MB Bowers Jr","year":"1984","unstructured":"Bowers MB Jr (1984) Homovanillic acid in caudate and pre-frontal cortex following neuroleptics. Eur J Pharmacol 99:103\u2013105","journal-title":"Eur J Pharmacol"},{"key":"BF00310514_CR10","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF00508472","volume":"296","author":"P Laduron","year":"1977","unstructured":"Laduron P, DeBie K, Leysen J (1977) Specific effect of haloperidol on dopamine turnover in the frontal cortex. Arch Pharmacol 296:183\u2013185","journal-title":"Arch Pharmacol"},{"key":"BF00310514_CR11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0014-2999(83)90604-0","volume":"89","author":"T Matsumoto","year":"1983","unstructured":"Matsumoto T, Uchimura H, Hirano M, Kim JS, Yokoo H, Shimomura M, Nakahara T, Inoue K, Oomagari K (1983) Differential effects of acute and chronic administration of haloperidol on homovanillic acid levels in discrete dopaminergic areas of brain. Eur J Pharmacol 89:27\u201333","journal-title":"Eur J Pharmacol"},{"key":"BF00310514_CR12","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/BF00508415","volume":"289","author":"B Scatton","year":"1975","unstructured":"Scatton B, Garret C, Julou L (1975) Acute and subacute effects of neuroleptics on dopamine synthesis and release in the rat striatum. Arch Pharmacol 289:419\u2013434","journal-title":"Arch Pharmacol"},{"key":"BF00310514_CR13","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0014-2999(77)90230-8","volume":"46","author":"B Scatton","year":"1977","unstructured":"Scatton B (1977) Differential regional development of tolerance to increase in dopamine turnover upon repeated neuroleptic administration. Eur J Pharmacol 46:363\u2013369","journal-title":"Eur J Pharmacol"},{"key":"BF00310514_CR14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF00569724","volume":"312","author":"SC Wheeler","year":"1980","unstructured":"Wheeler SC, Roth RH (1980) Tolerance to fluphenazine and supersensitivity to apomorphine in central dopaminergic systems after chronic fluphenazine decanoate treatment. Arch Pharmacol 312:151\u2013159","journal-title":"Arch Pharmacol"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00310514.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00310514\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00310514","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00310514.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T20:04:01Z","timestamp":1581969841000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00310514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1986,1]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1986,1]]}},"alternative-id":["BF00310514"],"URL":"https:\/\/doi.org\/10.1007\/bf00310514","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1986,1]]}}}